Stericycle (NASDAQ:SRCL) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Stericycle (NASDAQ:SRCLFree Report) in a research report report published on Saturday. The firm issued a hold rating on the business services provider’s stock.

SRCL has been the topic of several other reports. Wells Fargo & Company boosted their price target on Stericycle from $40.00 to $48.00 and gave the company an underweight rating in a research note on Friday, March 1st. Truist Financial boosted their price objective on Stericycle from $50.00 to $62.00 and gave the company a hold rating in a research report on Tuesday, June 4th. Keefe, Bruyette & Woods raised their target price on Stericycle from $135.00 to $142.00 and gave the stock an outperform rating in a research report on Tuesday, June 4th. Robert W. Baird lowered their price target on shares of Stericycle from $62.00 to $55.00 and set a neutral rating on the stock in a report on Friday, April 26th. Finally, Royal Bank of Canada reaffirmed a sector perform rating and set a $62.00 price objective (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of Hold and an average price target of $74.00.

Get Our Latest Research Report on SRCL

Stericycle Stock Performance

Shares of NASDAQ SRCL opened at $57.95 on Friday. Stericycle has a 12 month low of $37.78 and a 12 month high of $59.45. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.55. The company has a market cap of $5.38 billion, a P/E ratio of -263.41, a P/E/G ratio of 3.13 and a beta of 1.11. The business’s 50 day moving average is $52.07 and its two-hundred day moving average is $50.92.

Stericycle (NASDAQ:SRCLGet Free Report) last released its earnings results on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, beating the consensus estimate of $0.54 by $0.03. The firm had revenue of $664.90 million during the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The business’s quarterly revenue was down 2.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 EPS. On average, equities analysts expect that Stericycle will post 2.32 EPS for the current year.

Institutional Investors Weigh In On Stericycle

Several large investors have recently made changes to their positions in the company. Clearstead Trust LLC acquired a new position in Stericycle in the first quarter valued at about $25,000. Principal Securities Inc. acquired a new position in shares of Stericycle in the 4th quarter worth approximately $41,000. GAMMA Investing LLC grew its position in Stericycle by 170.9% during the 1st quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock worth $43,000 after acquiring an additional 516 shares during the last quarter. TFO Wealth Partners LLC increased its holdings in Stericycle by 22,325.0% during the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock valued at $44,000 after purchasing an additional 893 shares in the last quarter. Finally, Headlands Technologies LLC bought a new position in Stericycle in the 1st quarter valued at $44,000. Institutional investors own 98.82% of the company’s stock.

Stericycle Company Profile

(Get Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

See Also

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.